TruBridge Merger Clears HSR Hurdle, Awaits Shareholder Vote
TBRG sits 88% above its 52-week low of $13.88.
Summary
The Hart-Scott-Rodino (HSR) waiting period for TruBridge's acquisition by IKS Health has expired, removing a significant regulatory hurdle. This follows the definitive agreement announced in April for an all-cash transaction at $26.25 per share. The company filed a definitive proxy statement in early June, and the merger now only requires stockholder approval and other customary closing conditions. This development de-risks the deal and moves it closer to completion.
At the time of this announcement, TBRG was trading at $26.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $391.6M. The 52-week trading range was $13.88 to $26.51. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.